Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.31 -0.19 (-0.37%)

Streaming Delayed Price Updated: 3:31 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

45 46 Next >

GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations ↗

November 11, 2022

Via Benzinga

Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗

November 10, 2022

Via Benzinga

Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles ↗

November 10, 2022

Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.

Via Investor's Business Daily

GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care ↗

November 07, 2022

Via Benzinga

Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex ↗

November 05, 2022

Deals, financings, trials and approvals in Chinese biotech/biopharma this week.

Via Talk Markets

Why Vir Biotechnology Jumped Nearly 19% Today ↗

November 04, 2022

A COVID-19 partnership with a major drugmaker is producing more fruit than expected.

Via The Motley Fool

Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early ↗

November 03, 2022

Via Benzinga

GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat ↗

November 02, 2022

Shingrix and specialty medicines helped drive GSK's third-quarter growth.

Via Investor's Business Daily

GSK Lifts Annual Outlook After Robust Vaccines, Specialty Medicine Sales In Q3 ↗

November 02, 2022

Via Benzinga

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth ↗

November 04, 2022

Sales of Vir Biotechnology and GSK's Covid antibody almost tripled sales estimates.

Via Investor's Business Daily

Moderna's Earnings Collapsed. Time to Sell? ↗

November 04, 2022

This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills.

Via The Motley Fool

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02 ↗

November 02, 2022

Reuters

Via Benzinga

Recap: GSK Q3 Earnings ↗

November 02, 2022

GSK (NYSE:GSK) reported its Q3 earnings results on Wednesday, November 2, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings GSK beat estimated earnings by 15.63%,...

Via Benzinga

GSK's Debt Overview ↗

November 01, 2022

Over the past three months, shares of GSK Inc. (NYSE:GSK) decreased by 16.74%. Before having a look at the importance of debt, let's look at how much debt GSK has.

Via Benzinga

GSK Pulls Plug On Late-Stage Asset Under Development For Rheumatoid Arthritis ↗

October 27, 2022

Via Benzinga

GSK One Step Closer To FDA Approval For Anemia Drug For Dialysis Patients ↗

October 27, 2022

Via Benzinga

GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions ↗

October 25, 2022

Via Benzinga

Earnings This Week: AMD, BP And PayPal ↗

October 28, 2022

Find out what to expect from this week's earnings calendar.

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

October 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

GSK Q3 2022 Earnings Conference Call On November 2, 2022 At 08:00 AM ET ↗

October 28, 2022

GSK (NYSE:GSK) will host a conference call at 08:00 AM ET on November 2, 2022, to discuss Q3 2022 earnings results. How to Attend GSK (GSK) Conference Call Follow this link to access the live webcast.

Via Benzinga

Is Merck Moving Toward Another Blockbuster Drug Launch? ↗

October 26, 2022

Merck will soon share its positive phase 3 clinical trial results for a rare disease drug candidate at an upcoming event.

Via The Motley Fool

GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day ↗

October 25, 2022

Via Benzinga

3 Things the Smartest Investors Know About This Beaten-Down Stock ↗

October 20, 2022

Moderna's story may just be beginning.

Via The Motley Fool

GSK Plc (NYSE:GSK) Investor Alert: Investigation over Potential Wrongdoing ↗

October 21, 2022

San Diego, CA -- (SBWIRE) -- 10/21/2022 -- An investigation was announced on behalf of investors in NYSE:GSK shares over potential breaches of fiduciary duties by certain officers and directors at GSK...

Via SBWire

Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids ↗

October 21, 2022

Physicians are reporting a sharp increase in cases of the respiratory syncytial virus (RSV), creating capacity issues in several children's hospitals in the U.S. before the typically busier winter...

Via Benzinga

Peering Into GSK's Recent Short Interest ↗

October 20, 2022

GSK's (NYSE:GSK) short percent of float has risen 12.86% since its last report. The company recently reported that it has 15.83 million shares sold short, which is 0.79% of all regular shares that are...

Via Benzinga

Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny ↗

October 20, 2022

Boston University created an artificial form of COVID-19 in a laboratory. Now, U.S. health officials have launched an inquiry into a controversial study. The Boston University research was designed to...

Via Benzinga

7 Quality Stocks Selling at a Discount as Q4 Kicks Off ↗

October 19, 2022

Stocks may have just entered a bull market, so bullish investors should look for quality stocks selling at a discount to buy before a rally.

Via InvestorPlace

This Addiction Drug Shows Some Potential Against Long COVID Symptoms ↗

October 19, 2022

Researchers are working on cures for long COVID. With some success, naltrexone has been used to treat pain, fatigue, and brain fog months after a coronavirus infection.

Via Benzinga

Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm' ↗

October 17, 2022

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.